What is Pfizer's market cap?

Pfizer (PFE) has a market capitalization of $137.07B and trades on NYSE.

What is Pfizer's revenue and profitability?

Pfizer generated $63.3B in trailing twelve-month revenue with net income of $12.1B, representing a net margin of 15.7%. Gross margin stands at 73.5%, with free cash flow of $12.5B. These figures are based on the Q1 2026 filing.

Who are Pfizer's competitors?

Pfizer's key competitors include Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., and others. These companies compete in similar markets and product categories.

Who does Pfizer partner with?

Pfizer's notable partners include World Health Organization.

Where is Pfizer headquartered?

Pfizer is headquartered in United States of America and employs approximately 88,000 people. It has been publicly traded since 1951.

Pfizer

PFE

Pfizer is a global research-based biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of medicines and vaccines.

Market cap

$137.07B-5.0%

Revenue$63.3B+1.4%

Net income$12.1B+50.7%

Free cash flow$12.5B+26.6%

EPS (diluted)$2.12+50.3%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$14.5BBeat by $610.8M EPS$0.75Beat by $0.04

Read the full report

Next report

Aug 4, 2026 (In 3 weeks)

Revenue estimate$14.4B

EPS estimate$0.68

Financials

Q1 2026

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation & ratios

Valuation

See full

Market cap$137.07B-5.0%

Enterprise value$199.74B-2.3%

P/E11.3×—

P/S2.2×-0.1×

Profitability

See full

Gross margin73.5%+1.2pp

Returns & leverage

See full

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Segments

By product

See full

Eliquis$2.2B+12.6%

Prevnar Family$1.7B+1.8%

Vyndaqel family$1.6B+7.8%

Ibrance$1.0B+3.2%

All Other Hospital and Biosimilars$953.0M—

By geography

See full

International Developed Markets$3.4B+7.8%

International Emerging Markets$2.3B+6.0%

By segment

See full

Biopharma$14.2B+5.4%

Competitors

By market cap

Johnson & Johnson$634.06B+68.9%

AbbVie$446.54B+33.6%

Merck & Co.$311.17B+53.1%

Pfizer$137.07B-5.0%

Bristol-Myers Squibb$117.50B+23.1%

Roivant Sciences$26.0B+247%

Viatris$19.4B+77.4%

AYTU BioPharma, Inc.$23.4M+9.3%

By revenue growth

AbbVie+9.5%

Johnson & Johnson+7.9%

Merck & Co.+2.9%

Bristol-Myers Squibb+1.8%

Viatris+1.6%

Pfizer+1.4%

Roivant Sciences-71.6%

By net margin

Johnson & Johnson21.83%-2.6pp

Pfizer15.65%+6.3pp

Bristol-Myers Squibb15.01%+3.8pp

Merck & Co.13.59%-13.7pp

AbbVie5.79%-1.5pp

Viatris-2.04%+24.4pp

Roivant Sciences-6,079.94%—

Profile

Pfizer is a global research-based biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of medicines and vaccines. The company focuses on delivering innovative treatments across various therapeutic areas, including oncology, immunology, and infectious diseases, while navigating highly regulated global markets. Its core value proposition centers on leveraging large-scale R&D investment to address significant unmet medical needs and maintaining a differentiated product pipeline.

Competitive position

A leading global biopharmaceutical innovator that competes on the basis of efficacy, safety, and the ability to maintain market exclusivity through robust intellectual property protection.

GeographiesUnited States, European Union, China, Japan, United Kingdom

Customer segmentsHealthcare Providers, Government Entities, Patients, Payors

Business modelResearch and Development, Manufacturing, Intellectual Property Licensing

SuppliersRaw material suppliers, Contract research organizations, Specialized chemical manufacturers

CustomersDrug wholesalers, Pharmacy benefit managers (PBMs), Hospitals and clinics, Government health authorities, Retail pharmacies

CountryUnited States of America

Listed1951

Employees88.0K

CEOAlbert Bourla

SectorHealthcare

IndustryDrug Manufacturers - General

Websitepfizer.com

FilingsSEC EDGAR

Ask your AI about Pfizer.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's market cap?: Pfizer (PFE) has a market capitalization of $137.07B and trades on NYSE.
What is Pfizer's revenue and profitability?: Pfizer generated $63.3B in trailing twelve-month revenue with net income of $12.1B, representing a net margin of 15.7%. Gross margin stands at 73.5%, with free cash flow of $12.5B. These figures are based on the Q1 2026 filing.
Who are Pfizer's competitors?: Pfizer's key competitors include Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., and others. These companies compete in similar markets and product categories.
Who does Pfizer partner with?: Pfizer's notable partners include World Health Organization.
Where is Pfizer headquartered?: Pfizer is headquartered in United States of America and employs approximately 88,000 people. It has been publicly traded since 1951.